Key result
Admission lactate concentration was independently associated with 30-day mortality in patients with suspected STEMI.
Why the study?
Does admission lactate concentration predict 30-day mortality in patients admitted with suspected STEMI?
Cohort (n=2,094)
Does admission lactate concentration predict 30-day mortality in patients admitted with suspected STEMI?
Admission lactate concentration provides independent prognostic information for 30-day mortality in suspected STEMI patients, improving risk stratification beyond standard clinical and hemodynamic variables.
Answers are grounded in this paper and cite their sources.
May support lactate assessment in suspected STEMI; leaves open whether routine use improves outcomes.
AIMS: The diagnosis of cardiogenic shock depends on clinical signs of poor perfusion and low blood pressure. Lactate concentration will increase with poor tissue perfusion, and it has prognostic value in cardiogenic shock patients. We sought to assess the prognostic value of lactate concentration in subjects admitted with suspected ST-elevation myocardial infarction (STEMI). METHODS AND RESULTS: In 2,094 (93%) out of 2,247 consecutive suspected STEMI-subjects, lactate concentration was measured on admission. The prognostic value of lactate concentration on 30-day mortality was assessed in addition to clinical signs of peripheral hypoperfusion, systolic blood pressure (sBP), and left ventricular ejection fraction (LVEF) in multivariable models.Lactate concentration added prognostic information beyond signs of peripheral hypoperfusion, sBP, and LVEF, and was independently associated with 30-day mortality (hazard ratio [95% confidence interval] 1.11 [1.07-1.14], P < 0.0001). Lactate also provided predictive information on 30-day mortality to the combination of signs of peripheral hypoperfusion, sBP, and LVEF (area under the receiver-operating characteristics curve = 0.88 vs. 0.83, P < 0.0001). CONCLUSIONS: In conclusion, admission lactate concentration in suspected STEMI-subjects contains prognostic information on 30-day mortality when added to variables used in cardiogenic shock-definition. We recommend lactate measurement in STEMI-subjects, especially when signs of compromised hemodynamics are present.
No takes yet. Share an insight, caveat, or question.
Frydland et al. (2018) conducted a cohort in Suspected ST-elevation myocardial infarction (STEMI) (n=2,094). Admission lactate concentration was evaluated on 30-day mortality (HR 1.11, 95% CI 1.07-1.14, p=< 0.0001). Admission lactate concentration was independently associated with 30-day mortality in patients with suspected STEMI.
Synapse has enriched 10 related papers. Consider them for comparative context: